Our Blog

Illustration of a small woman standing on a laptop interacting with the trial metrics on the screen
Articles

6 Key Clinical Trial Metrics to Evaluate Your Patient Recruitment Campaigns

May 20, 2024

Sponsors who evaluate key recruitment metrics during patient recruitment campaigns set their trials up for success. See which metrics to track, and how.

Illustration representing online learning
Articles

3 Benefits of StudyTeam’s Online Learning Portal for Research Sites

May 6, 2024

The StudyTeam Learning Center shows new users how to work within StudyTeam. Read on for three benefits to using the STLC online learning portal.

Illustration of a woman looking at a sheet of paper with icons representing different aspects of a clinical trial
Articles , Clinical Trial Design

3 Ways to Design a Clinical Trial That’s Patient-Centric

March 11, 2024

Build patient-centricity into clinical trial design to improve patient recruitment, engagement, and retention. Read about 3 ways to support that process.

Circle of China's flag with the StudyTeam logo above it
Articles

Research Sites Can Now Use StudyTeam Technology to Enroll Clinical Trials in China

February 6, 2024

Research sites can now use StudyTeam technology to more efficiently manage patient recruitment and enrollment for clinical trials in China.

To directional signs pointing towards enrollment or screening
Articles , Patient Screening , Clinical Trial Enrollment

The Difference Between Screening and Enrollment in Clinical Trials

January 23, 2024

Screening is one piece of the patient enrollment period. Keep reading to learn the difference between screening and enrollment in clinical trials.

Illustration of a woman looking at patient data labelled with the Denmark flag
Articles , Clinical Trial Workflow

Challenges and Solutions for Clinical Trial Sites: Hear From a Doctor at Esbjerg Hospital in Denmark

January 3, 2024

Hear from Dr. Elise Jonasson Nielsen at the Esbjerg Hospital in Denmark as she discusses site challenges and the technology to solve them.